ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3012

Over-Expression of Ubiquitin-Specific Peptidases in Systemic Sclerosis Fibroblasts Increases Responses to TGF-Beta

Christine Galant, Joëlle Marchandise, Julie Ducreux, Maria Stoenoiu, Frédéric A. Houssiau and Bernard R. Lauwerys, Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibrosis, pathogenesis and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ubiquitination of proteins leads to their degradation by the proteasome, and is regulated by a small number of ubiquitin ligases, and a large number of susbtrate-specific ubiquitin-specific peptidases (USP). The ubiquitination process is not only key to protein recycling, and cell survival but plays also important roles in the regulation of cell metabolism and cell cycle. Here, we found that the expression of several USP is increased in systemic sclerosis tenosynovial biopsies, and we demonstrated that USP inhibition decreases TGFβ signaling in primary fibroblast cell lines.

Methods: HGU133 Plus2.0 arrays were hybridized with total RNA obtained from 5 tenosynovial samples obtained in patients with SSc and overt tenosynovial involvement, and compared to disease control synovial biopsies. Primary fibroblast cell lines were obtained from the skin of SSc patients or controls, and cultured in the presence of DMOG, a HIF1α hydroxylase inhibitor or in the presence of TGFβ +/- USP inhibitor NS-632839. HEK293 cells were stably transfected with an USP15-encoding expression plasmid.

Results: Transcriptomic profiles of tenosynovial biopsies from SSc patients were characterized by the expression of genes involved in known pathogenic pathways : fibrosis, Wnt signaling, but also by the over-expression of  several USP (USP15, 16, 18, 25, 31, 36, 37, 45, 48). Immunohistochemistry experiments on the same samples confirmed the presence of USP15 in SSc biopsies.

Culture of primary fibroblast cell lines in the presence of DMOG, a HIF1α-hydroxylase inhibitor that mimics the effects of hypoxia, results in a significant induction of TGFβ, USP25 and USP36 gene expression, but not USP15.

USP15 is known to specifically deubiquinate SMAD3, and we confirmed that over-expression of USP15 in HEK293 cells results in increased SMAD3, and SMAD3 phosphorylation in response to TGFβ stimulation. Conversely, exposure of cultured fibroblasts to NS-632839, a pan-USP inhibitor decreased SMAD3 expression and phosphorylation, and expression of COLIAI, COL3A1 and fibronectin gene expression in response to TGFβ stimulation. The effect of the USP inhibitor resulted in increased SMAD3 ubiquitination (as proven by SMAD3 immunoprecipitation experiments), and was blocked by epoxomicin, a proteasome inhibitor, thereby confirming the specificity of its action.

Conclusion: Over-expression of several USP, including USP15, is observed in tenosynovial biopsies from SSc patients, and is not fully explained by the effects of hypoxia. USP15 amplifies fibrotic responses induced by TGFβ, and is a potential therapeutic target in SSc.


Disclosure: C. Galant, None; J. Marchandise, None; J. Ducreux, None; M. Stoenoiu, None; F. A. Houssiau, None; B. R. Lauwerys, None.

To cite this abstract in AMA style:

Galant C, Marchandise J, Ducreux J, Stoenoiu M, Houssiau FA, Lauwerys BR. Over-Expression of Ubiquitin-Specific Peptidases in Systemic Sclerosis Fibroblasts Increases Responses to TGF-Beta [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/over-expression-of-ubiquitin-specific-peptidases-in-systemic-sclerosis-fibroblasts-increases-responses-to-tgf-beta/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/over-expression-of-ubiquitin-specific-peptidases-in-systemic-sclerosis-fibroblasts-increases-responses-to-tgf-beta/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology